
A recent study examined the potential benefits of vagus nerve stimulation (VNS) for rheumatoid arthritis (RA) patients. The randomized, double-blind, sham-controlled trial included RA patients who had not responded to conventional drugs. The patients were given an auricular vagus nerve stimulator and randomized into two groups: active stimulation or sham. The primary goal was to determine the proportion of patients achieving a 20% improvement in the American College of Rheumatology criteria (ACR20) after 12 weeks. The study found that VNS did not significantly improve RA disease activity.
Like
Save
Share